Abstract:Background: Despite being the second most common type of neurodegeneration with brain iron accumulation, there is limited literature on PLA2G6-associated neurodegeneration (PLAN) within the Asian ethnicity, particularly in the Indian context. Methods: We conducted a retrospective observational study on patients with pathogenic/likely pathogenic PLA2G6 variants based on exome sequencing. Results: We identified 26 patients (22 families, 15 males) of genetically-confirmed PLAN with a median age of 22.5 years and age at onset of 13.0 years, encompassing various subtypes: infantile neuroaxonal dystrophy (5/26;19.2%), atypical neuroaxonal dystrophy (3/26;11.5%), dystonia-parkinsonism (5/26;19.2%), dystonia-parkinsonism-myoclonus (n = 4, 15.38%), early-onset Parkinson's disease (2/26;7.7%), complex dystonia (2/26;7.7%), and complicated hereditary spastic paraparesis (cHSP; 5/26;19.2%). The common initial symptoms included walking difficulty (7/26;26.9%), developmental regression (6/26;23.1%), and slowness (4/26;15.4%). Dystonia (14/26;53.8%), followed by parkinsonism (11/26; 42.3%), was the most common motor symptom. Non-motor symptoms included cognitive decline (12/26;46.2%) and behavioral changes (6/26;23.1%). Neuroimaging revealed cerebellar atrophy in 23/26 (88.5%) patients and claval hypertrophy in 80% (4/5) of INAD patients. Levodopa responsiveness was noted in 12 of 14 patients with parkinsonism/dystonia who received levodopa, and dyskinesia was noted in 10/11 patients. Genetic analysis revealed a total of 19 unique variants in PLA2G6 gene, of which 11 were novel. Twelve patients harbored the c.2222G>A variant, which is predominantly seen in Asian subpopulations. Conclusions: The study introduces 26 new patients of PLAN and 12 patients associated with the c.2222G>A variant, potentially forming the most extensive single center series to date. It also expands the phenotypic, neuroimaging, and genotypic spectrum of PLAN.

Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies

PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes

Ipla2β Contributes to ER Stress-Induced Apoptosis During Myocardial Ischemia/Reperfusion Injury

A systematic analysis of genotype–phenotype associations with PLA2G6

The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization

Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration.

Neurodegeneration associated with genetic defects in phospholipase A(2)

Novel PLA2G6 Pathogenic Variants in Chinese Patients With PLA2G6-Associated Neurodegeneration

Ipla(2)beta( )and Its Role in Male Fertility, Neurological Disorders, Metabolic Disorders, and Inflammation

Phospholipase D, a Novel Therapeutic Target Contributes to the Pathogenesis of Neurodegenerative and Neuroimmune Diseases

iPLA2β loss leads to age-related cognitive decline and neuroinflammation by disrupting neuronal mitophagy

Calcium-independent Phospholipases A2 and Their Roles in Biological Processes and Diseases

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration

Follow-Up Study of 25 Chinese Children with Pla2g6-Associated Neurodegeneration

The Impact of the Ca2+-Independent Phospholipase A2β (ipla2β) on Immune Cells

The Clinical, Radiological and Genetic Spectrum of PLA2G6-Associated Neurodegeneration: An Experience From a Tertiary Center

Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration

Phospholipases A2 and Inflammatory Responses in the Central Nervous System

The Clinical Characteristics and Molecular Genetics of Infantile Neuroaxonal Dystrophy: the Current Research Progress

Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice

Clinical Study and PLA2G6 Mutation Screening Analysis in Chinese Patients with Infantile Neuroaxonal Dystrophy